BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190723
DTEND;VALUE=DATE:20190726
DTSTAMP:20260515T010840
CREATED:20190404T071545Z
LAST-MODIFIED:20190404T071545Z
UID:20177-1563840000-1564099199@www.pharmajournalist.com
SUMMARY:2nd Neuropsychiatric Drug Development Summit
DESCRIPTION:THE INDUSTRY’S DEFINITIVE MEETING TO ADVANCE THE DEVELOPMENT OF CLINICALLY TRANSFORMATIVE NEUROPSYCHIATRIC DRUGS \n \nWith the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available\, the development of the next generation of neuropsychiatric drugs is essential. \nThe abundance of excitement and scientific progress in the field – especially with the recent approval of esketamine – will be captured at the Neuropsychiatric Drug Development summit\, in Boston on July 23 – 25\, 2019. \nBuilt with thought-leaders at Sage Therapeutics\, Johnson & Johnson and Lundbeck\, the 2nd Annual NPD summit will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs. \nDedicated to overcoming challenges in neuropsychiatric drug development\, this comprehensive discussion and networking forum will cover: \n\nReviewing the current clinical landscape to share learned lessons\, predict potential success and identify future opportunities\nDetermine what we can expect from neuropsychiatric preclinical models to better predict clinical efficacy\nUtilize what we know from the clinical to improve our use of translational strategies\nDiscuss the potential for digital therapeutics to transform the success of efficacious pharmaceuticals\nReview symptomatic focused drug development to identify the benefits and impact future regulation\nEvaluate the potential for different neuropsychiatric targets by improving our understanding of neuropsychiatric biology\nImproving our understanding of the role of genetics in neuropsychiatry and debating the future of precision medicine for neuropsychiatric disorders\n\nJoin your peers at NPD to be part of the cross-industry discussion on latest developments\, insights and science to elevate clinically effective neuropsychiatric therapeutic pipelines \nTo learn more about this event\, visit https://ter.li/belugv
URL:https://www.pharmajournalist.com/event/2nd-neuropsychiatric-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190813
DTEND;VALUE=DATE:20190816
DTSTAMP:20260515T010840
CREATED:20190530T091644Z
LAST-MODIFIED:20190530T091644Z
UID:20938-1565654400-1565913599@www.pharmajournalist.com
SUMMARY:B3DD Summit
DESCRIPTION:The Blood-Brain Barrier Delivery Summit (B3DD) is the industry’s first conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates. \n \nWith an emphasis on biologics\, and built with the field’s leading minds from the likes of Biogen\, Genentech\, Armagen & Denali\, the B3DD Summit will unite over 60 industry stakeholders giving you the opportunity to develop new partnerships and build on existing relationships to ensure you have the connections to accelerate your drug’s development. \nSome of the highlights include: \n\nAssessing Microphysiological Models of the BBB – Biogen\nEmploying in vivo Microdialysis & Microperfusion Methods to Understand Brain Disposition of Biologics for the Treatment of CNS Disorders – AbbVie\nClinical Efficacy of Antibody-enzyme Fusion Proteins as Carrier Platform to Transport Lysosomal Enzymes Across the BBB for the Treatment of Mucopolysaccharidosis Type I\nPKPD of Different Therapeutic Modalities for CNS Indications – Genentech\nExplaining Clinical Failures – Is Efficacy or Delivery to Blame?- Merck\, Lundbeck\, AbbVie\n\nTo learn more about B3DD Summit\, and to register online\, visit https://ter.li/7vs04e
URL:https://www.pharmajournalist.com/event/b3dd-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190820
DTEND;VALUE=DATE:20190823
DTSTAMP:20260515T010840
CREATED:20190529T091738Z
LAST-MODIFIED:20190529T091738Z
UID:20911-1566259200-1566518399@www.pharmajournalist.com
SUMMARY:2nd Annual Hemophilia Drug Development Summit
DESCRIPTION:Given the excitement and anticipation of increasingly more promising prophylactic treatments and gene therapies\, the 2nd Annual Hemophilia Drug Development Summit\, once again unites leading pharma\, biotech and academic KOLs working to translate and clinically develop longer acting and more efficacious therapies to overcome significant unmet medical need and hemophilia and other bleeding disorders. \n \nAttend the 2nd Hemophilia Drug Development Summit to identify novel drug development strategies and overcome the shared translational\, clinical development and delivery challenges to dramatically improve patient outcomes. \nSounds interesting? Find out more – get free event brochure here: https://ter.li/4snxn9
URL:https://www.pharmajournalist.com/event/hemophilia-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190822
DTEND;VALUE=DATE:20190824
DTSTAMP:20260515T010840
CREATED:20190531T125458Z
LAST-MODIFIED:20190531T125545Z
UID:21020-1566432000-1566604799@www.pharmajournalist.com
SUMMARY:4th Annual Medical Device Regulatory and Quality Summit 2019
DESCRIPTION:4th Annual Medical Device Regulatory and Quality Summit 2019 will create a platform for regulators\, industry stalwarts to come under one roof to discuss and share ideas that would not only benefit their organisations\, but at large the industry as well. The 4th Annual Medical Device Regulatory and Quality Summit 2019 will review the evolving regulations\, their impact on the industry as well as take an in depth look into areas of quality control and assurance. \n \nTo learn more about this event\, and to register online\, visit http://bit.ly/2MgH15z
URL:https://www.pharmajournalist.com/event/4th-annual-medical-device-regulatory-and-quality-summit-2019/
LOCATION:New Delhi\, India
ORGANIZER;CN="Inventicon Business Intelligence":MAILTO:pooja.mishra@inventicon.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190827
DTEND;VALUE=DATE:20190830
DTSTAMP:20260515T010840
CREATED:20180531T135859Z
LAST-MODIFIED:20190430T084109Z
UID:16049-1566864000-1567123199@www.pharmajournalist.com
SUMMARY:3rd Annual IPF Summit
DESCRIPTION:The IPF Summit focuses exclusively on closing the translational gap between preclinical predictability and clinical attrition to accelerate the development of truly curative idiopathic pulmonary fibrosis (IPF) therapeutics. \n \nWith the 2019 conference expanding upon an even greater breadth and depth of content\, you’ll hear three days of unrivalled scientifically driven and case-study based analysis and discussion\, as together leading academia and biopharma advance the IPF drug development frontier. \nLast year\, over 90 of IPF’s expert drug developers came together to advance the standardisation of imaging\, share clinical insights\, and evaluate better recapitulating disease physiology in vitro exclusively for IPF: \n“This was a superb meeting combining several emerging themes in IPF therapies and a dynamic mix of formal presentations with impromptu networking. All the speakers were excellent\, and every session provided novel and important insight regarding IPF. The effort the speakers put into their presentations was evident. Great job!” \nCeders-Sinai Medical Center \nWith the incredible breakthrough success of drugs now in our arsenal for slowing IPF disease progression\, the increasing importance of identifying genetic mechanisms\, closing the translational gap between preclinical and clinical results\, and developing candidates to reverse fibrosis have opened up further challenges within IPF drug development. \nJoin “part 3” as the IPF community converges again to: \n\nAnalyze the latest understanding of IPF pathology for improved target validation of next generation therapeutics and the potential to promote tissue regeneration to achieve reversal of fibrosis\nCritically discuss how to design the next generation of phase III clinical trials for candidate success in light of a current standard of care\nOutline progressions in the standardization of imaging and advancements of biomarkers to improve translational success and more confident diagnosis of patients\n\nTo learn more about 3rd Annual IPF Summit and to register online\, visit https://ter.li/i81anp \nContact \nEmail – info@hansonwade.com\nPhone – +1 415 735 3289
URL:https://www.pharmajournalist.com/event/ipf-summit/
LOCATION:Sheraton San Diego Hotel & Marina\, 1380 Harbor Island Drive\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190904
DTEND;VALUE=DATE:20190907
DTSTAMP:20260515T010840
CREATED:20190529T085545Z
LAST-MODIFIED:20190529T090758Z
UID:20888-1567555200-1567814399@www.pharmajournalist.com
SUMMARY:2nd Microbiome Movement - Skin Health & Dermatology Summit
DESCRIPTION:2nd Microbiome Movement – Skin Health & Dermatology Summit\nTranslate the Skin Microbiome into Safe\, Effective & Commercially Viable Dermatological Therapeutics & Cosmetic Products\n4-6 September 2019 | San Diego\nWebsite: https://ter.li/bsl3rt \nAs scientific researchers continue to investigate the complexities of the skin microbiome\, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple: Build a collaborative forum that unites forward thinking academic\, dermatological & cosmetic researchers\, and lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing solutions that modify the skin microbiome to treat disease (therapeutics) or support overall skin health (cosmetics). \n \nOur conversations have highlighted that although a strong commercial opportunity exists\, there are critical areas of basic science that need addressing including study design to elucidate host-microbiome interactions\, selecting the right tools to make clear correlations between microbial dysbiosis and skin disease and standardization of sample collection and analysis. \nIf you’re keen to make sense of skin microbiome science and its application to the therapeutic and cosmetic industry\, join over 100+ scientifically-driven researchers from academia\, biopharma and the cosmetic community to help you discover\, translate and commercialize breakthrough therapeutics or cosmetics that improve skin health. \nEarly booking and group discounts are available. Visit the website to learn more: https://ter.li/bsl3rt
URL:https://www.pharmajournalist.com/event/2nd-microbiome-movement-skin-health-dermatology-summit/
LOCATION:The Westin San Diego\, 400 West Broadway\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@microbiome-movement.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190904
DTEND;VALUE=DATE:20190907
DTSTAMP:20260515T010840
CREATED:20190708T094531Z
LAST-MODIFIED:20190708T094531Z
UID:21492-1567555200-1567814399@www.pharmajournalist.com
SUMMARY:3D Tissue Models Summit
DESCRIPTION:The 3D Tissue Models Summit will bring together 120+ industry stakeholders across the regulatory\, pharma\, biotech and academic landscapes to discuss the latest insight into established validation techniques to increase reproducibility and improve the preclinical effectiveness of drug candidates. \nJoin us and discover: \n20+ latest case studies showcasing the advantages of high throughput screening techniques across the 3D model continuum to drive drug discovery progress. \nFDA guidance into the regulatory landscape to define a common language of key terms across the industry for end users. \nNIH and IQ Consortia discussing the latest developments to incorporate platform-specific standardization and reproducibility metrics for organoids and tissue chip technology. \nModel developers and academic experts revealing how to overcome translational challenges to define disease-relevant endpoints across a variety of model types. \nTake advantage of this unrivalled learning and networking opportunity packed with content and dedicated interactive formats to ensure you leave equipped with the connections and takeaways to enhance the predictive success of your preclinical 3D models.
URL:https://www.pharmajournalist.com/event/3d-tissue-models-summit/
LOCATION:Hilton Boston Back Bay  40 Dalton St  Boston\, MA  02115\, USA
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190910
DTEND;VALUE=DATE:20190912
DTSTAMP:20260515T010840
CREATED:20190522T082604Z
LAST-MODIFIED:20190522T082604Z
UID:20829-1568073600-1568246399@www.pharmajournalist.com
SUMMARY:Pharma and Device Packaging and Labelling Europe 2019
DESCRIPTION:After a successful European launch\, a special thank you to all our attendees at the Pharma Packaging and Labelling Conference! Arena International is delighted to announce we will be returning to Munich in 2019 for another superb year. \nWe have welcomed more than 100 attendees from across the region for two days of engaging presentations from the biggest names in the sector. \nThe 2018 programme looked at ongoing regulations\, ensuring patient safety and making sure the right systems are in place which is more crucial than ever with the ever looming FMD regulations. Top pharmaceutical companies\, biotechs\, CMOs and medical device companies such as Abbott\, Sandoz\, Coloplast\, AbbVie\, Novartis\, Roche; including regulatory bodies GS1\, EAASM and many more came together to share their insights into compliant packaging and labelling implementation. \nPharma Packaging and Labelling Europe will be returning in September 2019. We look forward to seeing you all there!
URL:https://www.pharmajournalist.com/event/pharma-and-device-packaging-and-labelling-europe-2019/
LOCATION:Munich\, Germany
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190910
DTEND;VALUE=DATE:20190914
DTSTAMP:20260515T010840
CREATED:20190607T133410Z
LAST-MODIFIED:20190607T133524Z
UID:21126-1568073600-1568419199@www.pharmajournalist.com
SUMMARY:5th Annual CAR-TCR Summit
DESCRIPTION:The definitive\, world-renowned summit dedicated to providing comprehensive insight into the full end-to-end pharmaceutical value chain for CAR-TCR therapies in liquid and solid tumor indications. \nThe CAR-TCR Summit remains at the forefront of the industry bringing you never-seen-before data from the movers and shakers in CAR and TCR therapy development. \n \nDedicated to discussing the next generation candidates beyond CD19\, from solid tumor indications to autoimmune disorders\, this meeting provides an in depth breakdown of the current strategies to optimize the durability\, persistence and targeting of approved and novel therapies to reduce relapse rates and overcome toxicity. \nAt the premier\, end-to-end summit focused on early research through to commercialization\, join the experts to discuss how to streamline process development and logistics supply chains for affordable and accessible CAR-TCR therapeutics. \nTake advantage of the unrivalled networking opportunities as we bring together over 1000 industry leaders developing CAR-TCR based therapies from across pharma\, biotech\, regulatory bodies\, academia\, solution and service providers. \nHere’s a snapshot of the 140+ world class speaker faculty: \n\nJames Noble\, Chief Executive Officer\, Adaptimmune\nBarbra Sasu\, Chief Scientific Officer\, Allogene\nChris Haqq\, Chief Scientific Officer\, Atara Biotherapeutics\nElsy Boglioli\, Chief Operating Officer\, Cellectis\nJean-Pierre Latere\, Chief Operations Officer\, Celyad\nKatherine Szarama\, Evidence Development Division\, Coverage & Analysis Group\, Center for Clinical Standards and Quality\, Centers for Medicare & Medicaid Services\nCheng Liu\, Chief Executive Officer\, Eureka Inc.\nJason Krentz\, Chief Technology Officer\, Tmunity Therapeutics\nThomas Andresen\, Chief Scientific Officer\, Torque Therapeutics\nMatthew Spear\, Chief Medical Officer\, Poseida Therapeutics\n\nDownload the event guide for the full details of the speaker line-up\, agenda and discounts available.
URL:https://www.pharmajournalist.com/event/5th-annual-car-tcr-summit/
LOCATION:Seaport Hotel & World Trade Center\, One Seaport Lane\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190916
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T010840
CREATED:20190213T095145Z
LAST-MODIFIED:20190214T154239Z
UID:19528-1568592000-1568937599@www.pharmajournalist.com
SUMMARY:TIDES: Oligonucleotide & Peptide Therapeutics Digital Week
DESCRIPTION:4-day complimentary series of live educational webcasts and downloadable resources uncovering insights to accelerate oligonucleotide and peptide products from early discovery to commercialization. \n \nWhy Attend A Webinar?\n \n\nTime and Cost Efficient\nYou will save valuable time and money because there is no need to travel and no registration fee.\nFocused and Timely Learning\nYou will receive the latest “hot” and timely data from a leading authority\nConvenience\nYou can participate in a webinar from a location of your choosing – your home\, your office\, or a client/customer location\n\nSign up now: www.TIDESDigitalWeek.com
URL:https://www.pharmajournalist.com/event/tides-oligonucleotide-peptide-therapeutics-digital-week/
LOCATION:MA
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190917
DTEND;VALUE=DATE:20190919
DTSTAMP:20260515T010840
CREATED:20190529T090623Z
LAST-MODIFIED:20190529T090623Z
UID:20904-1568678400-1568851199@www.pharmajournalist.com
SUMMARY:Inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit
DESCRIPTION:Inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit\nAdvance the Next Generation of Safe\, Effective & Commercially Viable Microbiome-Based Therapeutics & Nutritional Products\n17-18 September 2019 | Singapore\nWebsite: https://ter.li/tf7voy \n \nPart of the globally recognised Microbiome Movement\, we are delighted to announce the arrival of the inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit to help translational microbiome researchers in APAC discover\, develop and deliver the future generation of microbiome-based products across therapeutic and nutritional industry applications. \nThis year’s forum will play an important role in reviewing the major scientific and commercial progress areas in microbiome research in APAC but also help you stimulate new business opportunities in a new and exciting field. Join and interact with industry and academic key opinion leaders from Asia’s prominent microbiome-focused organisations at this year’s forum to accelerate your knowledge of the field\, overcome key challenges in translating your microbiome research to commercial reality and help deliver a new future for healthcare. \nEarly booking and group discounts are available. Visit the website to learn more: https://ter.li/tf7voy
URL:https://www.pharmajournalist.com/event/drug-development-nutrition-asia-summit/
LOCATION:Hilton Singapore\, 581 Orchard Rd\, 238883\, Singapore
ORGANIZER;CN="Hanson Wade":MAILTO:info@microbiome-movement.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190917
DTEND;VALUE=DATE:20190921
DTSTAMP:20260515T010840
CREATED:20190705T113213Z
LAST-MODIFIED:20190708T075127Z
UID:21440-1568678400-1569023999@www.pharmajournalist.com
SUMMARY:13th Digital Pharma East
DESCRIPTION:The 13th Digital Pharma East\, http://bit.ly/307A0WT\,  returns to the Pennsylvania Convention Center\, September 17-20. Discover how you can present business plans\, justify budget\, innovation and de-risk proposals when you join us for this annual event. Register with Discount Code DPE19PJ to secure your seat\, http://bit.ly/2xsmS2a. \nMake sure to download the brochure to see what’s on the agenda: http://bit.ly/2Jak8gN
URL:https://www.pharmajournalist.com/event/13th-digital-pharma-east/
LOCATION:Pennsylvania Convention Center
ORGANIZER;CN="ExL Events%2C a division of Questex%2C LLC":MAILTO:exlcontact@questex.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T010840
CREATED:20190613T103849Z
LAST-MODIFIED:20190613T111335Z
UID:21149-1568764800-1568937599@www.pharmajournalist.com
SUMMARY:7th Annual IMPACCT: RWE
DESCRIPTION:Returning for its 7th year\, IMPACCT: RWE provides top innovators and leaders in the real world evidence space with a comprehensive industry forum dedicated to supporting and advancing the generation and utilization of real world evidence across drug life cycle\, from clinical development to commercialization. \nJoin your peers and leading experts for a collaborative open discussion aiming to tackle key challenges to accelerate the meaningful implementation of real world evidence approaches to enhance clinical R&D outcomes\, drive patient-centricity\, and maximize the success of launch and commercialization activities. \nReal world evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real world into their development programs\, drug developers are now able to drive more patient-facing outcomes\, by supporting it with effective evidence-based decision-making across the product life cycle. \nAt a point of increasing maturity\, regulatory acceptance\, and growing innovation\, these are exciting times for all stakeholders actively involved in the efforts to advance the effective utilization and generation of real world evidence. \nLeading experts in the space will be tackling questions and sharing the latest case-studies around the use of RWE in: \n\nPatient identification\nClinical trial design\nHistoric control arms\nOutcomes research\nObservational research\nPost-launch safety studies\nDefining medical affairs strategy\nValue generation across the product life cycle\nRegulatory decision-making\nLabel extensions\nPatient access\n\n… and more. \nJoin them at this collaborative discussion platform that aims to bring together stakeholders from functions across clinical development\, HEOR\, regulatory and medical affairs\, epidemiology and RWE\, to overcome key challenges to define and implement a meaningful evidence generation plan that can effectively enhance clinical R&D\, support regulatory submission and decision-making\, and ultimately drive commercial success. \nTo learn more and to register online\, visit: https://impacct-rwe.com/
URL:https://www.pharmajournalist.com/event/7th-annual-impacct-rwe/
LOCATION:Aloft Boston Seaport District  401-403 D Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@impacct-rwe.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T010840
CREATED:20190613T104247Z
LAST-MODIFIED:20190613T105859Z
UID:21153-1568764800-1568937599@www.pharmajournalist.com
SUMMARY:2nd Annual AI-ML Clinical Development Summit
DESCRIPTION:Optimize When & How to Practically Apply AI & Machine Learning to Improve the Efficiency\, Patient Recruitment\, Design and Outcomes of Clinical Trials \nDesigned with leading AI and R&D experts from the likes of GSK\, Pfizer\, Takeda\, Celgene\, AbbVie and academic KOLs\, & containing real world use cases of AI in action\, this year’s AI-ML: Clinical Development Summit tackles both the critical scientific and technical challenges\, as well as identifying opportunities\, of implementing AI and machine learning (ML) to optimize your clinical development. \nThis is a critical time for drug developers to make more data-driven decisions that lead to improved efficacy\, safety and approval outcomes. Only here you will learn when\, strategically\, it is the right time to invest and apply AI to transform your clinical trial success. \nAs clinical failure rates remain unsustainable and the vast amounts of patient data increases further\, AI\, data and clinical development and pharmacovigilance experts from across large pharma and biotech are gathering to discover the growing practical applications of AI and ML. \nWith 60+ thought-leaders converging at the AI-ML Clinical Development Summit\, this will surely be an unrivalled opportunity for you to learn first-hand the growing practical applications of AI and ML. \n\nDiscover how to technically integrate and apply AI algorithms to enhance trial design\, improve patient selection and retention and achieve more precise pharmacovigilance studies.\nGrasp how AI will fundamentally change the paradigm of clinical trial execution and identify key areas where AI can positively impact your drug development decision making.\nHarness AI and extract maximum value to achieve regulatory success and accelerate novel therapeutic products to market.\n\nTo learn more and to register online\, visit: https://ai-clinicaldevelopment.com/
URL:https://www.pharmajournalist.com/event/2nd-annual-ai-ml-clinical-development-summit/
LOCATION:Aloft Boston Seaport District  401-403 D Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@ai-clinicaldevelopment.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190919
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T010840
CREATED:20190805T111428Z
LAST-MODIFIED:20190805T111428Z
UID:21848-1568851200-1568937599@www.pharmajournalist.com
SUMMARY:2nd Annual Pharma Packaging\, Labelling\, Serialisation\, Track and Trace 2019
DESCRIPTION:2nd Annual Pharma Packaging\, Labelling\, Serialisation\,\nTrack and Trace 2019\n“Securing your Supply Chain and Quality Management”\n19th September 2019\, Kohinoor Continental Hotel\, Mumbai\, India \n2nd Annual Pharma Packaging\, Labelling\, Serialisation\, Track and Trace 2019 overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems\, this conference addresses serialisation; track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products. Please contact me on KAVITHA at Email: kavitha@virtueinsight.co.in or Call: +91 9940791115. \nCONFERENCE DELEGATE REGISTRATION: \nIn order to register contact us on E-mail – kavitha@virtueinsight.co.in  Tel: +91 44 24762472 OR M: +91 9940791115 \nPlease note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite\, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.  \n\nEarly Bird Discount Price (Valid until 06th August)  – 1 Delegate – (INR 10\,000 + GST (18%) per delegate) \nStandard Price (Valid From 07th August)  – 1 Delegate – (INR 15\,000 + GST (18%) per delegate) \nFor Bulk Booking of More Than 5 Delegates – Please let us know your interests.\n\nCONFERENCE SPONSORSHIP: \nE-mail – kavitha@virtueinsight.co.in  in Tel: +91 44 24762472 Or M: +91 9940791115 \nSponsor\, Exhibition Stall (Booth) and a paid Speaker Slots are also available. \nWe also have some sponsorship opportunities available for the event\, which gives you an opportunity to sponsor/speak/exhibit\, and create brand awareness. In addition\, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. \n  \nIntroducing the First list of confirmed Speakers  \n\nK. BANGARURAJAN\, Joint Drugs Controller (INDIA)\, CDSCO (HQ)\nRUBINA BOSE\, Deputy Drugs Controller(India)\, CDSCO (WZ)\nMAYUR PARMAR  \, Deputy Collector\, Government Of Gujarat\nSUDHIR MOHAN BANSAL\, Vice President & India Head of Supply Chain Management\, Pfizer\nAMIT KALE\, Associate Vice President – Packaging and Automation\, Reliance\nOMPRAKASH S. SADHWANI\, Former Joint Commissioner and controlling Authority Food and Drug Administration (Maharashtra state)\nCHANDRA SEKHAR\, Vice President Quality\, Reliance Life Sciences\nUDAYKUMAR RAKIBE\, Founder\, PharmaMantra\nVAIBHAV KULKARNI\, Director – Regulatory Affairs\, Abbott Nutrition\nNARESH TONDARE\, Senior Director – National Regulatory Affairs\, Biocon\nSUNIL ACHARYA  \, Packaging Development\, S.C.P.L\nRITESH GOHEL\, Lead\, Global Serialisation and Track & Trace\, Sun Pharma\nS.R.SALUNKHE\, Former Assistant commissioner – FDA Maharashtra\nPRABIR DAS\, Head – Packaging Tech Services\, OSD\, Mylan Laboratories\nSANJAY KUMAR\, Head Of Legal\, Emcure Pharmaceuticals \nSANJAY DAVE\, CCO\, Anfarnd Consultancy Services\nVISHWAS SOVANI\, Founder Director\, Pharmawisdom\nGAURAJ SHAH\, Counsel\, Bombay High Court\nVIRENDRA SINGH\, Senior Manager\, Reliance Life Sciences\nJAGDISH VYAS\, Manager\, Abbott\nRAJSHRI CHETAN PARDESHI\, Manager – New Product & Commercial Packaging Development\, and Sourcing Head for Regulated Market\, Unosource Pharma (An Akums Enterprise)\nDARSHAN VARTAK \, Head Packaging Technical\, Anchor by Panasonic\n\nPlus many more \nWHO SHOULD ATTEND: \nCEO’s\, CTO’s\, CIO’s\, Presidents\, Vice Presidents\, Directors Heads & Managers of: \nPharmaceutical manufacturers and distributors\, Healthcare professionals\, Pharmacists\, Serialisation\, Track and Trace – Solution providers\, Brand – protection\, enforcement\, security\, integrity and management companies\, Drug regulatory agencies\, customs and police\, Intergovernmental organizations (IGOs) involved in healthcare and IPR protection\, Non-governmental organizations (NGOs) active in healthcare\, Patients’ representatives\, Healthcare research organizations\, Pharmaceutical associations\, Anti-counterfeiting organizations\, Packaging\, labeling and converting companies\, Authentication technology suppliers\, Anti-counterfeiting service suppliers – IP specialists\, investigators\, lawyers. \nGet more from the event\, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time\, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
URL:https://www.pharmajournalist.com/event/2nd-annual-pharma-packaging-labelling-serialisation-track-and-trace-2019/
LOCATION:Kohinoor Continental Hotel\, Mumbai\, India\, Mumbai\, India
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190926
DTSTAMP:20260515T010840
CREATED:20180630T165012Z
LAST-MODIFIED:20190607T095126Z
UID:16582-1569283200-1569455999@www.pharmajournalist.com
SUMMARY:The Skin Microbiome Congress Westcoast
DESCRIPTION:The microbiome is set to be one of 2019’s biggest skincare trends\, therefore we are incredibly excited to bring The Skin Microbiome Congress back to San Francisco for the 6th event in our global series. \n \nLast year\, we connected 600+ industry leaders from pharma\, beauty and personal care multinational brands with innovative independent skincare brands\, bio-techs\, researchers and academics who are advancing the skincare industry. This year\, we continue to focus on developing a functional understanding of the skin microbiome\, keeping up with the latest scientific research and competitive intelligence\, as well as focusing on ‘the business of skin microbiome’ – commercializing the trend. \nWHAT MAKES 2019 DIFFERENT? \nNew topics including skin microbiome based-products\, skin conditions\, personalization\, skin-gut supplements\, anti-ageing and commercializing ethically marketed and clinically proven products; as well as presenting the latest academic research – more researchers than ever will be showcasing the latest developments from top universities. \nAlso new for 2019\, we are co-locating with our Microbiome Consumer Nutrition Congress – tailor your agenda and learn about the relationship of skin/gut microbiome and supplements. \nOur 2018 event SOLD OUT\, so make sure you don’t miss out! Download our agenda now. \nTo learn more about The Skin Microbiome Congress WestCoast\, and to register online\, visit https://go.kisacoresearch.com/l/678123/2019-05-30/5hp8 \nContact:\nPhone: +44 (0)203 897 6822\nEmail: mh@kisacoresearch.com
URL:https://www.pharmajournalist.com/event/skin-microbiome-congress-westcoast/
LOCATION:Hotel Kabuki\, 1625 Post St\, San Francisco\, CA\, 94115\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:mh@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190926
DTSTAMP:20260515T010840
CREATED:20190618T120255Z
LAST-MODIFIED:20190618T120255Z
UID:21237-1569283200-1569455999@www.pharmajournalist.com
SUMMARY:Microbiome Consumer Nutrition Congress
DESCRIPTION:The Human Microbiome is a hot bed for scientific innovation and represents a rapidly growing area of focus for nutritional companies. Rising consumer consciousness around personal healthcare and diet\, coupled with substantial improvements in R&D is fuelling a new wave of products that promote human gut health and wellbeing. The global probiotics market is expected to be worth $64 Bn by 2024\, an increase of $20bn from 2017. \nThe Microbiome Consumer Nutrition Congress connects the dots between business\, scientific innovation\, regulation and product development in the converging fields of functional foods\, pre/probiotics and the gut microbiome. \nTop 10 reasons to attend: \n\nConnect with and understand what leading nutrition\, consumer health and CPG companies look for when forming strategic partnerships.\nUnderstand the key branding and business features that VCs and Investors look for when investing in the next wave of gut health products\, and how to build an effective investment deck to support your company’s next round of fundraising.\nDiscover the key ingredients leading health and wellness retailers seek for the next best-selling pre/probiotic products.\nDiscover the latest advancements in personalized microbiome diagnostics and how these can be translated into nutrition programs and products.\nUnderstand the key business opportunities in the microbiome consumer nutrition space and how to capitalize on them.\nExpand your understanding of the modern health and wellness consumer\, the language they understand and what they’ll buy.\nApply the key take-aways from world leading microbiome consumer nutrition companies who have successfully branded and marketed their products and grown their businesses.\nDiscover the latest and most innovative scientific microbiome developments and how these can be utilized to develop the next generation of commercially successful consumer products.\nDevelop your understanding of regulatory considerations for microbiome-based products to improve the quality of your product’s claims and overcome regulation challenges.\nUnderstand the timing and cost realities of bringing a gut probiotic to market and utilize this knowledge to efficiently release your next product.
URL:https://www.pharmajournalist.com/event/microbiome-consumer-nutrition-congress/
LOCATION:Hotel Kabuki – 1625 Post St\, San Francisco\, California\, United States\, 94115
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190926
DTSTAMP:20260515T010840
CREATED:20190703T094347Z
LAST-MODIFIED:20190703T094347Z
UID:21427-1569283200-1569455999@www.pharmajournalist.com
SUMMARY:Asia Skin Microbiome 2.0 Congress
DESCRIPTION:This 2-day congress includes both scientific and commercial interests with topics ranging from host-microbe interaction\, skin disease\, emerging technologies\, interventional and cosmetic advancements\, and regulatory considerations. It features new and exciting case studies\, presentations and expert-led panel discussions and an exhibition of solution providers showcasing products\, and ample networking opportunities. \nSpecific focus areas include: \n\nSkin health\, wellbeing\, and microbiome-associated skin disease\nSkin immunology / Microbe-host interaction\nMicrobe-based therapies\nEmerging technologies for skin microbiome research and innovation\nCosmetic vs Therapeutic regulatory considerations\nCase studies / Academic-Commercial partnerships\n\n10% OFF – code : sk/smca/10 expire on 26th Aug 2019. Contact :  saffuan@global-engage.com for group booking
URL:https://www.pharmajournalist.com/event/asia-skin-microbiome-2-0-congress/
LOCATION:Singapore – Hotel Fort Canning
ORGANIZER;CN="Global Engage":MAILTO:saffuan@global-engage.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190925
DTEND;VALUE=DATE:20190927
DTSTAMP:20260515T010840
CREATED:20190402T114527Z
LAST-MODIFIED:20190402T114527Z
UID:20170-1569369600-1569542399@www.pharmajournalist.com
SUMMARY:Biobanking 2019
DESCRIPTION:With the estimated revenues of the global biobanking industry reaching US$ 27.54 billion in 2020\, backed by an explosive CAGR of 9.5% between now and 2026. This market growth is fuelled by the increasing drive towards precision and personalised medicine and thus\, quality biosamples are now in soaring demand. \n \nCome join us in September 2019 and; thoroughly understand the latest developments in the biobanking industry; network with the industry experts and key opinion leaders; gain insight into how the biobanking industry at the forefront at driving precision medicine and enhancing research and discover ‘Drone4Care’\, how drone delivery of biosamples can be a reality. \nThe event will bring together internationally recognised biorepositories\, scientific pioneers from pharmaceutical companies\, and academics to strengthen current knowledge in biosample management and their research applications. We will cover the most relevant hot topics including: the latest biorepository technological breakthroughs\, the best practices in biobanking\, shifts in the biosample regulation landscape\, the international biobank societies with ESBB and ISBER\, along with a whole host of successful biobanking business model structures to help reinvigorate your biobank.  \nBenefits of attending: \n\nDiscover ‘Drone4care’ from Laurent Dollé\, the innovative and daring plan to use drones for the delivery of biomaterial. Additionally\, he will be detailing the new promising technology of Tissue Microarray\, a bioprocessing technology that can reduced the number of needed biosamples for research from 200 down to 1\n\n\nHear from UK Biobank on the continual impact of GDPR on the biobanking landscape\n\n\nLearn about a diverse range of the most successful biobanking business models from real case studies\n\n\nGain insight from the global biobank collaboration societies of ESBB and ISBER\, see how you can place your biobank on the international stage\n\nView the full agenda online: \nEarly bird rates: \n\nBOOK BY 30TH APRIL AND SAVE £400\nBOOK BY 31ST MAY AND SAVE £300\nBOOK BY THE 28TH JUNE AND SAVE £200\n\nPlus\, two interactive half day pre-conference workshops: \nWorkshop A: Enhance your biobank’s commercial prowess through the application of financial and economic tools along with how to improve your biosamples data quality\nWorkshop Leader: Laurent Dollé\, Managing Director\, BWB (Biothèque Wallonie Bruxelles)\n8.30 – 12.30 \nWorkshop B: The Organic Development of a Sustainable Academic Biobank\nWorkshop Leader: Mary-Beth Joshi\, Director\, Biobank & translational Research Core\, Duke University Medical Centre\n1.30 – 5.30 \nFollow us:  @SMiPharm #smibiobanking \nTo learn more and to register online\, visit www.biobanking-event.com/Pharmajwl
URL:https://www.pharmajournalist.com/event/biobanking-2019/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Limited":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190925
DTEND;VALUE=DATE:20190927
DTSTAMP:20260515T010840
CREATED:20190404T105139Z
LAST-MODIFIED:20190404T105139Z
UID:20198-1569369600-1569542399@www.pharmajournalist.com
SUMMARY:SMi’s 10th Annual Biosimilars Conference
DESCRIPTION:Conference:  Wednesday 25 and Thursday 26 September 2019\nWorkshop: Tuesday 24th September 2019 \nChaired by Michel Mikhail\, International Expert Regulatory Affairs\, Global Expert Biosimilars \nDiscussing future regulatory\, commercial and legal challenges of biosimilars \nSMi Group are delighted to announce the 10th annual Biosimilars Conference taking place on 25th and 26th September 2019. This year’s event will be our first global event taking place in London\, UK. The event’s focus is to highlight the current challenges in the biosimilars market and discuss current undergoing plans or developments to overcome these challenges. \nThe biosimilars market is forecasted to reach USD$23.6B by 2023 at a compound annual growth rate (CAGR) of 31.70%. Factors driving the increase of this market include growing demand for biosimilar drugs due to their cost-effectiveness\, growing incidence of chronic diseases\, and strategic collaborations resulting in enhanced productivity and clinical trial activities. \nWith the expiry dates of major patents fast approaching\, the emerging gap in the market for biosimilars is now a major attraction for manufacturers. As the availability of biosimilars could potentially reduce direct spending by USD$54B by 2026\, the question is what can current biosimilar producing companies do to join this market to benefit the patients\, physicians and investors? \n BENEFITS OF ATTENDING \n\nHEAR about current strategies under development to overcome challenges with patents currently faced by many biosimilar developers\nDISCUSS the possible changes in regulatory approval of biosimilars in the UK post Brexit\, and how this will impact market entry\nEXPLORE the latest methods in use to maintain the relationship between stakeholders\, doctors and patients\, with the influence of governing bodies\nREVIEW FDA regulations for the approval of Biosimilars and the latest approvals\n\nPLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS\nTuesday 24th September 2019\, Copthorne Tara Hotel\, Central London\, UK \nA: US-FDA Interchangeability Guideline\n08.30 – 12.30\nWorkshop Leader: Michel Mikhail\, International Expert Regulatory Affairs\, Global Expert of Biosimilars \nB: Global Development of Biosimilars – what can the US learn from Europe’s Strategies to promote biosimilar uptake\n13:30 – 17:30\nWorkshop Leader: Rodeina Challand\, General Manager\, Challand Biosimilar Consulting \nWHO SHOULD ATTEND? \nPresidents\, Vice Presidents\, Managing Directors\, Directors\, Associate Directors\, Chiefs\, Heads\, Principals\, Managers and Analysts of: \n\nBiosimilar Development\nProduct Development\nCommercialization\nMarket Access\nMedical Affairs\nIntellectual Property\nBioloigcs\nBiopharmaceuticals\nResearch and Development\nGenerics\nBiobetters\nBusiness Development\nStrategic Marketing\nDrug Development\nClinical Trials\nImmunogenicity Studies\n\nGlobal Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK\, Europe and USA. \nEARLY BIRD-RATES \n\nBOOK BY 30TH APRIL AND SAVE £400\nBOOK BY 31ST MAY AND SAVE £300\nBOOK BY 28TH JUNE AND SAVE £200
URL:https://www.pharmajournalist.com/event/smis-10th-annual-biosimilars-conference/
LOCATION:Copthorne Tara Hotel\, London\, UK\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191002
DTEND;VALUE=DATE:20191004
DTSTAMP:20260515T010840
CREATED:20190606T122433Z
LAST-MODIFIED:20190606T123252Z
UID:21055-1569974400-1570147199@www.pharmajournalist.com
SUMMARY:The Marketing Disruption Summit USA
DESCRIPTION:Harness data & tech to engage customers and dominate markets  \nAs consumer attitudes shift to “one-click” pharma needs to shift with it. \nImproving customer engagement strategies and processes are the key to improving reputations and delivering value. But how do we get there? \nThe answer\, we can’t do it alone. The responsibility to deliver an excellent customer engagement strategy sits across several functions\, at eyeforpharma Marketing Disruption Summit USA we’ll be going beyond the theoretical and bringing together all stakeholders to deliver a blueprint to revitalize customer relationships. \n2019 Expert speakers include: \n\nAnish Shindore\, Head of Digital Acceleration\, Sanofi\nMartina Flammer\, SVP\, Customer Value\, Boehringer Ingelheim\nJudith Lyster\, Digital/IT Leader Canada\, Eli Lilly & Co.\nMatt Smith\, Global Lead\, Strategy\, Digital & Operations\, Pfizer\nChad Dau\, Head of Business and Market Analytics\, Astellas\nRamon Vega\, Director\, Global Pharma Marketing IT\, Merck\n\nOver 200 attendees from across both front-end and back-end: Marketers\, IT/technology\, transformation agents\, Data\, Field Operations and more…will discuss how to unify efforts and develop strategy and process that performs in the field. \nWith the latest case studies from Sanofi\, Pfizer and Ouchie\, panels led by pharma leaders and out of industry expert sessions that will help you create the ultimate\, effortless customer engagement strategy– this is the event to ensure your business is ready to dominate the market.
URL:https://www.pharmajournalist.com/event/the-marketing-disruption-summit-usa/
LOCATION:Sheraton Philadelphia Society Hill Hotel
ORGANIZER;CN="eyeforpharma":MAILTO:sburbach@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191008
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T010840
CREATED:20190703T092011Z
LAST-MODIFIED:20190703T092011Z
UID:21420-1570492800-1570751999@www.pharmajournalist.com
SUMMARY:19th Pharmacovigilance 2019
DESCRIPTION:19th Pharmacovigilance 2019 \n“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance\, drug safety and risk management” \n08th – 10th October 2019\, Hotel TBC\, Cambridge\, Boston\, USA \n19th Pharmacovigilance 2019 will bring together top pharmaceutical\, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.  The entire program will cover the detection\, analysis and prevention of adverse drug reactions.  It will be studied with the help of case studies and industry experiences.  Hence\, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting Pv development. \nSPONSORS: \n\nGOLD SPONSOR: Brookwood\, AB Cube\, AWINSA Life Sciences \nBRONZE SPONSOR: 4C Pharma Solutions\n\nKEY SPEAKERS: \n\nDEREK ROY\, Resident Agent in Charge\, FDA\nBRUNO MENDEZ\, VP Global Quality Head Pharmacovigilance\, Sanofi\nMARIETTE BOERSTOEL-STREEFLAND\,  VP PharmacoVigilance & Drug Safety\, Alexion Pharmaceuticals\nTEGINDER SINGH\, Senior Director Global Regulatory Affairs\, Johnson & Johnson\nCOLLEEN WALSH\, Senior Director\, Pharmacovigilance & Regulatory Quality Management Operations\, Alexion Pharmaceuticals\nGERSON PELTZ\, Senior Director – Oncology Safety Risk Lead\, Pfizer\nBRUCE DONZANTI\, Senior Group Director\, Regulatory Pharmacovigilance Policy\, Genentech\nWILLIAM WANG\, Executive Director\, Clinical Safety Statistics\, Merck\nMELVIN MUNSAKA\, Senior Director\, Head Safety Statistics\, Abbvie\nXIAO NI\, Director\, Scientific Computing and Consulting\, Novartis\nSHARON REID\, Director\, Risk Management Product Lead\, Pfizer\nHARISHA KADALI\, Associate Medical Director\, Takeda Pharmaceuticals\nJAYLAXMI NALAWADE\, Associate Director – Pharmacovigilance and REMS\, Lupin\nRICHARD WOLF\, Executive Director\, Pv Operations\, CSL Behring\nPHIL TREGUNNO\, Group Manager – Vigilance\, Intelligence and Research Group\, MHRA (UK)\nTOYIN ADEWOLE\, Associate Director\, Drug Safety – Clinical Research\, Supernus Pharmaceuticals\nSHEETAL KHEDAR\, Senior Director\, Regulatory Science\, Sarah Cannon Development Innovations\nDAVID HUTCHINSON\, Founder\, Brookwood International Academy\nMELVA COVINGTON\, Senior Principal\, AGAPE Strategic Solutions\nBEN LOCWIN\, Senior Vice President\, Quality\, Lumicell\n\nWHO SHOULD ATTEND: \nCEO’s\, CTO’s\, CIO’s\, Presidents\, VPs\, Directors\, Heads\, Managers\, Scientific Advisors\, Consultants of: \nPharmacovigilance\, Pharmacoepidemiology\, Pharmacogenomics\, Drug/Product Safety\, Drug Development\, Information and Clinical Data Management\, Clinical Pharmacology\, Clinical Safety\, Periodical safety update Reports\, Risk Management\, Research & Development\, Quality Assurance\, Patient Safety\, Signal Detection\, Safety Surveillance\, Outcomes Research\, Data Analysis\, Epidemiology\, Medical Affairs\, Regulatory Affairs and Compliance\, Information technology\, Sales and Marketing \nCONFERENCE SPONSORSHIP: \n E-mail – kavitha@virtueinsight.co.in  or Tel: +44 2036120886 \n Sponsor\, Exhibition Stall (Booth) and a paid Speaker Slots are also available. \nWe also have some sponsorship opportunities available for the event\, which gives you an opportunity to sponsor/speak/exhibit\, and create brand awareness. In addition\, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. \nCONFERENCE REGISTERATION: \nIn order to register contact us on Email: kavitha@virtueinsight.co.in  Tel: +44 2036120886 \nConference Only: \n\nIntroductory Offer (3 delegate places for the price of 2) A huge saving (Limited seats left)\nEarly Discount (25th June 2019 – 19th August 2019): (£1299 per delegate)\nStandard Registration (20th August 2019 Onwards): (£1499 per delegate)\n\nConference + Workshop: \n\nIntroductory Offer (3 delegate places for the price of 2) A huge saving – (Limited seats left)\nEarly Discount (25th June 2019 – 19th August 201): (£1499 per delegate)\nStandard Registration (20th August 2019 Onwards): (£1699 per delegate)\n\nWorkshop Oniy – £399 \nWhether you are on the branded or generic side\, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway.  Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry\, research and development costs\, and regulatory hurdles\, which are balanced against an enormous potential for increased profit margins. Expand your knowledge of the latest business models and strategies in the high-level conference.
URL:https://www.pharmajournalist.com/event/19th-pharmacovigilance-2019/
LOCATION:Double Tree Suites by Hilton Hotel – 400 Soldiers Field Road\, Boston\, MA 02134
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191008
DTEND;VALUE=DATE:20191010
DTSTAMP:20260515T010840
CREATED:20190729T102418Z
LAST-MODIFIED:20190729T115346Z
UID:21733-1570492800-1570665599@www.pharmajournalist.com
SUMMARY:Blockchain for Health Supply Chain
DESCRIPTION:Blockchain for Health Supply Chain: Real-World Application is the definitive event for all key stakeholders across the supply chain to forge a path for collaboration and adoption of this transformative technology. Consortium and tech-agnostic\, this conference provides a neutral platform for cross-community sharing of PoCs and discussion about the common challenges facing all blockchain implementation projects. \n \nIn its 2nd year\, this event will continue to tackle the deep and difficult challenges associated with blockchain implementation – providing essential guidance for active adopters as well as those preparing to embark on their blockchain journey. Our mission is to help you get beyond PoC – and to get blockchain out of the lab and into business. \nFind out more – get free event brochure here:  https://ter.li/p0t4xu \nContact\n(+1) 617 455 4188\ninfo@hansonwade.com
URL:https://www.pharmajournalist.com/event/blockchain-for-health-supply-chain/
LOCATION:The Westin Boston Waterfront\, 425 Summer St\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191009
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T010840
CREATED:20190513T090618Z
LAST-MODIFIED:20190513T090618Z
UID:20692-1570579200-1570751999@www.pharmajournalist.com
SUMMARY:4th European Prefilled Syringes Summit
DESCRIPTION:After the three successful ACI’s European Prefilled Syringes Summit\, we are pleased to inform you that the 4th edition will take place this month on the 9th & 10th October in Berlin\, Germany. \n \nThe two day event will explore the advancements in regulatory guidelines including Article 117 and what this will mean for interactions with notified bodies. The conference will highlight technical advancements in product design and usage\, looking at the move towards autoinjectors. Our expert speakers will compare the use of glass syringes with plastic syringes\, focus on how to minimise the impact of extractables and leachables\, and address CCI regulations. Through in-depth presentations and interactive panel discussions\, the conference will shed light onto how the industry is responding to disruptive technology\, connectivity\, speed to market\, and next generation syringes. \nKey Topics Include: \n\nMedical Device Regulations overview and updates\nTechnical advancements in product design and usage\nSuitability of primary packaging components\nExtractables and leachables\nManufacturing and supply barriers\nImproving adherence through device innovation and human factors\nCreating value with connectivity\nDevelopments in biologics\nShifting to a pay-per-outcome market\n\nFor more information & 15% subscribers discounted registration\, contact Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net   \nJoin us in Berlin to exchange your point of view with your peers and engage in excellent networking opportunities.
URL:https://www.pharmajournalist.com/event/4th-european-prefilled-syringes-summit/
LOCATION:Berlin\, Germany
ORGANIZER;CN="Active Communications Europe Ltd (ACI)":MAILTO:mahsan@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191009
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T010840
CREATED:20190517T135859Z
LAST-MODIFIED:20190814T090558Z
UID:20796-1570579200-1570751999@www.pharmajournalist.com
SUMMARY:Pharmaceutical Cleanroom Technology Europe Conference
DESCRIPTION:SMi’s Pharmaceutical Cleanroom Technology Europe Conference\nConference: Wednesday 9 and Thursday 10 October 2019\nWorkshop: Tuesday 8 October 2019\nLocation: Copthorne Tara Hotel\, London\, UK\nwww.cleanroomtechnology.co.uk/pjwl  \nSponsored by: Contec and Dupont  \nCHAIRMAN: James Drinkwater\, Chairman\, Pharmaceutical & Healthcare Science Society  \nAddressing the Microbiological Aspects in Cleanroom Design and Engineering \nSMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference\, taking place on the 9th and 10th October 2019 in London\, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry\, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point. \n \nThis one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals\, biologicals\, and cleanroom industry experts to explore hot topics within cleanroom design and engineering\, best practices and regulation\, environmental and contamination control\, and pharmaceutical microbiology. \nIn 2025\, the global cleanroom technology market is expected to reach nearly $5 billion. Stringent regulatory standards for product approvals\, technological advancements in cleanrooms\, initiatives taken by private organisations to create awareness regarding cleanroom and growth of the healthcare sector globally are among the few factors expected to drive the market. \nCompliance with the standards for product approvals is crucial and as a result manufacturing companies in various industries are dependent on cleanroom technology.  \nBENEFITS OF ATTENDING \n\nEXPLORE the characteristics and relevance of air flow to better advise cleanroom design\, engineering and manage contamination\nDISCUSS the most current approaches to minimised cost and improved energy efficiency without compromising product quality\nEXAMINE the latest contamination control strategies from leaders in the pharmaceutical industry\nGAIN insight into cleaning and disinfection protocols from a risk-management approach\n\n PLUS AN INTERACTIVE HALF DAY PRE-CONFERENCE WORKSHOP \nTuesday 8th October 2019\, Copthorne Tara Hotel\, London\, UK \nEnvironmental Classification\, Qualification and Monitoring of GMP Controlled areas referencing ISO 14644-1 and risk based GMP \nWorkshop Leader: James Drinkwater\, Chairman\, Pharmaceutical and Healthcare Science Society \nWHO SHOULD ATTEND? \nSenior Micro Manager\, QC Manager\, Quality Director\, Clean Room Design Managers\, Design\, Qualify and Testing – Clean Room (across the board)\, Head of Clean Room Technologies\, Head of Compounding Pharmacies\, Head of Clinical Drug Products\, Head of Clinical Medical Device \nGlobal Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK\, Europe and USA. \nEARLY BIRD-RATES \n\nBOOK BY 31ST MAY AND SAVE £400\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30th AUGUST AND SAVE £200
URL:https://www.pharmajournalist.com/event/pharmaceutical-cleanroom-technology-europe/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010840
CREATED:20190124T074007Z
LAST-MODIFIED:20190124T074007Z
UID:19196-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Novel Antibody Therapeutics Congress
DESCRIPTION:The Novel Antibody Therapeutics Congress one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/novel-antibody-therapeutics-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010840
CREATED:20190124T074341Z
LAST-MODIFIED:20190124T074341Z
UID:19201-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Adoptive Cell Transfer Congress
DESCRIPTION:The Adoptive Cell Transfer Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/adoptive-cell-transfer-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010840
CREATED:20190124T074554Z
LAST-MODIFIED:20190124T074554Z
UID:19206-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:TMB & Neoantigen Congress
DESCRIPTION:The TMB & Neoantigen Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/tmb-neoantigen-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010840
CREATED:20190124T074802Z
LAST-MODIFIED:20190124T074802Z
UID:19211-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Liquid Biopsies Congress
DESCRIPTION:The Liquid Biopsies Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/liquid-biopsies-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010840
CREATED:20190124T075036Z
LAST-MODIFIED:20190124T075036Z
UID:19216-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Flow Cytometry Congress
DESCRIPTION:The Flow Cytometry is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/flow-cytometry-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
END:VCALENDAR